Thoracic Oncologic Surgery in 2025: Innovation and Re-Appraisal of Dogma

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Cecilia Pompili, MD, PhD

Loretta Erhunmwunsee, MD
Disclosure(s): Astrazeneca: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing); Bristol Myers Squibb Foundation: Advisory Board (Ongoing)

Presentations

  1. Annals Academy—Top 10 Questions in General Thoracic Surgery
    Brian Mitzman, MD, MS
    Disclosure(s): Intuitive Surgical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  2. Discussion
     
  3. Optimal Intrathoracic Pressure Setting Level of a Digital Thoracic Drainage System for Managing Air Leakage After Anatomical Pulmonary Resection: The Thop-Air Multicenter Randomized Controlled Trial
    Kazuhito Funai, MD, PhD
     
  4. Does Residual Apical Space (RAS) After Surgery in Persistent/Recurrent Primary Spontaneous Pneumothorax Prove to Be a Predictor Factor of Recurrence? Multicenter Analysis Stratified by Type of Surgery
    Antonio Giulio Napolitano, MD
     
  5. Does This Lymph Node Look Bulky to You? What Should We Do About It? A Survey of Thoracic Surgeons
    Ian C. Bostock, MD MS
     
  6. DOTATATE-PET has Low Sensitivity in Preoperative Nodal Staging of Carcinoid Tumors of the Lung
    Lillian L. Tsai, MD
     
  7. Thoracic Metastasectomy of Residual Germ Cell Tumor Metastases After Sequential High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Relapsed Patients
    Stefan Sponholz, MD
     
  8. Social Vulnerability Effects on Timeliness-to-Treatment for Patients with Localized Non-Small Cell Lung Cancer
    Jonathan E. Williams, MD
     
  9. Sublobar Resection Is Not Associated with Increased Risk of Recurrence in Stage I Non-Small Cell Lung Cancer with Lymphovascular Invasion
    Joshua R. Brady, MD, PhD
     
  10. 1,000 Robotic Navigational Bronchoscopies: Diagnostic Yield and Surgical Implications
    Andrew R. Brownlee, MD
     
  11. The Safety and Efficacy of Second Pulmonary Resections for Lung Cancer
    Hayley Reddington, MD
     
  12. Richard E. Clark Memorial Paper for General Thoracic Surgery: Lobectomy vs. Sublobar Resection Among Lung Cancer Patients Understudied in Recent Clinical Trials
    Gavitt A. Woodard, MD
    Disclosure(s): AstraZeneca: Advisory Board (Ongoing)
     
  13. Richard E. Clark Memorial Paper Discussant for General Thoracic Surgery
    Andrea Wolf, MD, MPH
     
  14. Audience Q&A
Activity summary
Available credit: 
  • 2.00 ABS Accredited CME
  • 2.00 ABTS Accredited CME
  • 2.00 AMA PRA Category 1 Credit
Activity opens: 
03/01/2025
Activity expires: 
03/01/2028
Cost:
$0.00
Rating: 
0

Available Credit

  • 2.00 ABS Accredited CME
  • 2.00 ABTS Accredited CME
  • 2.00 AMA PRA Category 1 Credit

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Cecilia Pompili, MD, PhD

Loretta Erhunmwunsee, MD
Disclosure(s): Astrazeneca: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing); Bristol Myers Squibb Foundation: Advisory Board (Ongoing)

Presentations

  1. Annals Academy—Top 10 Questions in General Thoracic Surgery
    Brian Mitzman, MD, MS
    Disclosure(s): Intuitive Surgical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  2. Discussion
     
  3. Optimal Intrathoracic Pressure Setting Level of a Digital Thoracic Drainage System for Managing Air Leakage After Anatomical Pulmonary Resection: The Thop-Air Multicenter Randomized Controlled Trial
    Kazuhito Funai, MD, PhD
     
  4. Does Residual Apical Space (RAS) After Surgery in Persistent/Recurrent Primary Spontaneous Pneumothorax Prove to Be a Predictor Factor of Recurrence? Multicenter Analysis Stratified by Type of Surgery
    Antonio Giulio Napolitano, MD
     
  5. Does This Lymph Node Look Bulky to You? What Should We Do About It? A Survey of Thoracic Surgeons
    Ian C. Bostock, MD MS
     
  6. DOTATATE-PET has Low Sensitivity in Preoperative Nodal Staging of Carcinoid Tumors of the Lung
    Lillian L. Tsai, MD
     
  7. Thoracic Metastasectomy of Residual Germ Cell Tumor Metastases After Sequential High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Relapsed Patients
    Stefan Sponholz, MD
     
  8. Social Vulnerability Effects on Timeliness-to-Treatment for Patients with Localized Non-Small Cell Lung Cancer
    Jonathan E. Williams, MD
     
  9. Sublobar Resection Is Not Associated with Increased Risk of Recurrence in Stage I Non-Small Cell Lung Cancer with Lymphovascular Invasion
    Joshua R. Brady, MD, PhD
     
  10. 1,000 Robotic Navigational Bronchoscopies: Diagnostic Yield and Surgical Implications
    Andrew R. Brownlee, MD
     
  11. The Safety and Efficacy of Second Pulmonary Resections for Lung Cancer
    Hayley Reddington, MD
     
  12. Richard E. Clark Memorial Paper for General Thoracic Surgery: Lobectomy vs. Sublobar Resection Among Lung Cancer Patients Understudied in Recent Clinical Trials
    Gavitt A. Woodard, MD
    Disclosure(s): AstraZeneca: Advisory Board (Ongoing)
     
  13. Richard E. Clark Memorial Paper Discussant for General Thoracic Surgery
    Andrea Wolf, MD, MPH
     
  14. Audience Q&A